To access the full text documents, please follow this link: http://hdl.handle.net/2445/32972

Antipsychotic polypharmacy in a regional health service: a population-based study
Bernardo Arroyo, Miquel; Coma, Anna; Ibáñez, Cristina; Zara, Corinne; Bari, Josep M.; Serrano Blanco, Antoni
Universitat de Barcelona
Background To analyse the extent and profile of outpatient regular dispensation of antipsychotics, both in combination and monotherapy, in the Barcelona Health Region (Spain), focusing on the use of clozapine and long-acting injections (LAI). Methods Antipsychotic drugs dispensed for people older than 18 and processed by the Catalan Health Service during 2007 were retrospectively reviewed. First and second generation antipsychotic drugs (FGA and SGA) from the Anatomical Therapeutic Chemical classification (ATC) code N05A (except lithium) were included. A patient selection algorithm was designed to identify prescriptions regularly dispensed. Variables included were age, gender, antipsychotic type, route of administration and number of packages dispensed. Results A total of 117,811 patients were given any antipsychotic, of whom 71,004 regularly received such drugs. Among the latter, 9,855 (13.9%) corresponded to an antipsychotic combination, 47,386 (66.7%) to monotherapy and 13,763 (19.4%) to unspecified combinations. Of the patients given antipsychotics in association, 58% were men. Olanzapine (37.1%) and oral risperidone (36.4%) were the most common dispensations. Analysis of the patients dispensed two antipsychotics (57.8%) revealed 198 different combinations, the most frequent being the association of FGA and SGA (62.0%). Clozapine was dispensed to 2.3% of patients. Of those who were receiving antipsychotics in combination, 6.6% were given clozapine, being clozapine plus amisulpride the most frequent association (22.8%). A total of 3.800 patients (5.4%) were given LAI antipsychotics, and 2.662 of these (70.1%) were in combination. Risperidone was the most widely used LAI. Conclusions The scant evidence available regarding the efficacy of combining different antipsychotics contrasts with the high number and variety of combinations prescribed to outpatients, as well as with the limited use of clozapine. Background To analyse the extent and profile of outpatient regular dispensation of antipsychotics, both in combination and monotherapy, in the Barcelona Health Region (Spain), focusing on the use of clozapine and long-acting injections (LAI). Methods Antipsychotic drugs dispensed for people older than 18 and processed by the Catalan Health Service during 2007 were retrospectively reviewed. First and second generation antipsychotic drugs (FGA and SGA) from the Anatomical Therapeutic Chemical classification (ATC) code N05A (except lithium) were included. A patient selection algorithm was designed to identify prescriptions regularly dispensed. Variables included were age, gender, antipsychotic type, route of administration and number of packages dispensed. Results A total of 117,811 patients were given any antipsychotic, of whom 71,004 regularly received such drugs. Among the latter, 9,855 (13.9%) corresponded to an antipsychotic combination, 47,386 (66.7%) to monotherapy and 13,763 (19.4%) to unspecified combinations. Of the patients given antipsychotics in association, 58% were men. Olanzapine (37.1%) and oral risperidone (36.4%) were the most common dispensations. Analysis of the patients dispensed two antipsychotics (57.8%) revealed 198 different combinations, the most frequent being the association of FGA and SGA (62.0%). Clozapine was dispensed to 2.3% of patients. Of those who were receiving antipsychotics in combination, 6.6% were given clozapine, being clozapine plus amisulpride the most frequent association (22.8%). A total of 3.800 patients (5.4%) were given LAI antipsychotics, and 2.662 of these (70.1%) were in combination. Risperidone was the most widely used LAI. Conclusions The scant evidence available regarding the efficacy of combining different antipsychotics contrasts with the high number and variety of combinations prescribed to outpatients, as well as with the limited use of clozapine.
-Antipsicòtics
-Utilització de medicaments
-Salut pública
-Barcelona (Catalunya)
-Antipsychotic drugs
-Drug utilization
-Public health
-Barcelona (Catalonia)
cc-by (c) Bernardo Arroyo et al., 2012
http://creativecommons.org/licenses/by/3.0/es/
Article
Article - Published version
BioMed Central Ltd
         

Show full item record

Related documents

Other documents of the same author

Aragonés-Benaiges, Enric; Bonet, Sara; Borrell, Manel; Cardoner, Narcís; Andrés, Ana M. de; Guerrero, Antoni; Ibáñez, Cristina; Pérez, Víctor
Feliu Soler, Albert; Borràs, Xavier; Penarrubia María, María T.; Rozadilla Sacanell, Antoni; Amico, Francesco D'; Moss-Morris, Rona; Howard, Matthew A.; Fayed, Nicolás; Soriano Mas, Carles; Puebla Guedea, Marta; Serrano Blanco, Antoni; Perez Aranda, Adrián; Tuccillo, Raffaele; Luciano, Juan V.
Rubio Valera, Maria; Serrano Blanco, Antoni; Travé i Mercadé, Pere; Peñarrubia María, María Teresa; Ruiz, Mar; March Pujol, Marian
Rubio Valera, Maria; Serrano Blanco, Antoni; Magdalena Belío, Jesús; Fernández Sánchez, Ana; García Campayo, Javier; March Pujol, Marian; López del Hoyo, Yolanda
 

Coordination

 

Supporters